Ubiquitech Software (Ubiquitech Software) Debt-to-Revenue : 6.81 (As of Aug. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Ubiquitech Software Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Ubiquitech Software's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was $0.02 Mil. Ubiquitech Software's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was $1.12 Mil. Ubiquitech Software's annualized Revenue for the quarter that ended in Aug. 2023 was $0.17 Mil. Ubiquitech Software's annualized Debt-to-Revenue for the quarter that ended in Aug. 2023 was 6.81.

Ubiquitech Software Debt-to-Revenue Historical Data

The historical data trend for Ubiquitech Software's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ubiquitech Software Debt-to-Revenue Chart

Ubiquitech Software Annual Data

Trend

Aug08

Debt-to-Revenue

N/A

Ubiquitech Software Quarterly Data
	Nov07	Feb08	May08	Aug08	Nov08	Feb09	May09	Aug09	Nov09	Feb10	May10	Aug22	Aug23
Debt-to-Revenue	Get a 7-Day Free Trial								N/A	N/A	N/A	-	6.81

Competitive Comparison of Ubiquitech Software's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ubiquitech Software's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ubiquitech Software's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ubiquitech Software's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ubiquitech Software's Debt-to-Revenue falls into.

Ubiquitech Software Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Ubiquitech Software's Debt-to-Revenue for the fiscal year that ended in Aug. 2008 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	N/A
	=	N/A

Ubiquitech Software's annualized Debt-to-Revenue for the quarter that ended in Aug. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.023	+	1.121)	/	0.168
	=	6.81

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Aug. 2023) Revenue data.

Ubiquitech Software Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ubiquitech Software's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ubiquitech Software (Ubiquitech Software) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ubiquitech Software Corp (OTCPK:UBQU) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3570 East 12th Avenue, Denver, CO, USA, 80206

Website

https://www.cannazall.com

Ubiquitech Software Corp is a United States-based multi-media, multi-faceted company. It is engaged in utilizing global internet marketing, direct response television, radio, and traditional marketing to drive traffic to the new industries. The company also focuses on developing Cannabidiol (CBD) Hemp derived products. It owns the proprietary CBD brand CannazALL. The company offers the products through its internally designed and operated web portal www.cannazall.com.

Executives

Young Yuen

director, 10 percent owner, officer: CEO/Pres/Secretary/Treasurer

7435 S. EASTERN AVENUE, SUITE 5, LAS VEGAS NV 89123